spacer
spacer

PDBsum entry 2jdf

Go to PDB code: 
protein links
Structural protein PDB id
2jdf

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
176 a.a. *
Waters ×238
* Residue conservation analysis
PDB id:
2jdf
Name: Structural protein
Title: Human gamma-b crystallin
Structure: Gamma crystallin b. Chain: a. Synonym: gamma-b crystallin, gamma crystallin 1-2. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.70Å     R-factor:   0.196     R-free:   0.220
Authors: H.Ebersbach,E.Fiedler,T.Scheuermann,M.Fiedler,M.T.Stubbs,C.Reimann, G.Proetzel,R.Rudolph,U.Fiedler
Key ref:
H.Ebersbach et al. (2007). Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein. J Mol Biol, 372, 172-185. PubMed id: 17628592 DOI: 10.1016/j.jmb.2007.06.045
Date:
08-Jan-07     Release date:   24-Jul-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P07316  (CRGB_HUMAN) -  Gamma-crystallin B from Homo sapiens
Seq:
Struc:
175 a.a.
176 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1016/j.jmb.2007.06.045 J Mol Biol 372:172-185 (2007)
PubMed id: 17628592  
 
 
Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein.
H.Ebersbach, E.Fiedler, T.Scheuermann, M.Fiedler, M.T.Stubbs, C.Reimann, G.Proetzel, R.Rudolph, U.Fiedler.
 
  ABSTRACT  
 
The concept of novel binding proteins as an alternative to antibodies has undergone rapid development and is now ready for practical use in a wide range of applications. Alternative binding proteins, based on suitable scaffolds with desirable properties, are selected from combinatorial libraries in vitro. Here, we describe an approach using a beta-sheet of human gamma-B-crystallin to generate a universal binding site through randomization of eight solvent-exposed amino acid residues selected according to structural and sequence analyses. Specific variants, so-called Affilin, have been isolated from a phage display library against a variety of targets that differ considerably in size and structure. The isolated Affilin variants can be produced in Escherichia coli as soluble proteins and have a high level of thermodynamic stability. The crystal structures of the human wild-type gamma-B-crystallin and a selected Affilin variant have been determined to 1.7 A and 2.0 A resolution, respectively. Comparison of the two molecules indicates that the human gamma-B-crystallin tolerates amino acid exchanges with no major structural change. We conclude that the intrinsically stable and easily expressed gamma-B-crystallin provides a suitable framework for the generation of novel binding molecules.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. A representation of bovine γ-B-crystallin used to model the human γ-B-crystallin scaffold, showing the C^α trace in cartoon representation and the accessible surface area. The eight selected amino acid residues (positions 2, 4, 6, 15, 17, 19, 36, and 38) used for library construction are highlighted in red. This Figure was generated using pdb entry 1AMM and the program PyMol [http://pymol.sourceforge.net/].
Figure 9.
Figure 9. Superposition of all C^α backbones (right) and of the N-terminal domain (left) of the crystal structure of human wild-type γ-B-crystallin (red) and of the IgG-Fc binding Affilin molecule SPC-1-G3 (blue). The superposition was performed using the program PyMol with rms values of 0.284 Å (N-terminal domain) [http://pymol.sourceforge.net].
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2007, 372, 172-185) copyright 2007.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19438717 D.Kapoor, B.Singh, K.Subramanian, and P.Guptasarma (2009).
Creation of a new eye lens crystallin (Gambeta) through structure-guided mutagenic grafting of the surface of betaB2 crystallin onto the hydrophobic core of gammaB crystallin.
  FEBS J, 276, 3341-3353.  
19501012 M.Gebauer, and A.Skerra (2009).
Engineered protein scaffolds as next-generation antibody therapeutics.
  Curr Opin Chem Biol, 13, 245-255.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer